Erlotinib synergizes with the poly(ADP-ribose) glycohydrolase inhibitor ethacridine in acute myeloid leukemia cells

Haematologica. 2016 Nov;101(11):e449-e453. doi: 10.3324/haematol.2016.146894. Epub 2016 Sep 1.
No abstract available

Publication types

  • Letter

MeSH terms

  • Cell Line, Tumor
  • Drug Synergism
  • Erlotinib Hydrochloride / pharmacology*
  • Erlotinib Hydrochloride / therapeutic use
  • Ethacridine / pharmacology*
  • Ethacridine / therapeutic use
  • Glycoside Hydrolases / antagonists & inhibitors
  • Humans
  • Leukemia, Myeloid, Acute / drug therapy
  • Leukemia, Myeloid, Acute / pathology*

Substances

  • Erlotinib Hydrochloride
  • Glycoside Hydrolases
  • poly ADP-ribose glycohydrolase
  • Ethacridine